Compare AANJANEYA LIFECARE with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PROCTER & GAMBLE HEALTH DR. DATSONS LABS/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -10.9 52.0 - View Chart
P/BV x 0.2 4.7 3.4% View Chart
Dividend Yield % 0.0 10.1 -  

Financials

 DR. DATSONS LABS   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PROCTER & GAMBLE HEALTH
Dec-18
DR. DATSONS LABS/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1263,549 3.5%   
Low Rs311,301 2.4%   
Sales per share (Unadj.) Rs133.0511.4 26.0%  
Earnings per share (Unadj.) Rs0.261.3 0.2%  
Cash flow per share (Unadj.) Rs6.674.0 8.9%  
Dividends per share (Unadj.) Rs0440.00 0.0%  
Dividend yield (eoy) %018.1 0.0%  
Book value per share (Unadj.) Rs128.8927.8 13.9%  
Shares outstanding (eoy) m31.6616.60 190.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.7 12.4%   
Avg P/E ratio x516.139.6 1,304.4%  
P/CF ratio (eoy) x11.832.8 36.1%  
Price / Book Value ratio x0.62.6 23.2%  
Dividend payout %0717.9 0.0%   
Avg Mkt Cap Rs m2,47740,257 6.2%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m561,313 4.3%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m4,2118,490 49.6%  
Other income Rs m79244 32.3%   
Total revenues Rs m4,2898,734 49.1%   
Gross profit Rs m5691,482 38.4%  
Depreciation Rs m204211 96.8%   
Interest Rs m4300-   
Profit before tax Rs m131,514 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m6563 1.1%   
Profit after tax Rs m51,017 0.5%  
Gross profit margin %13.517.5 77.4%  
Effective tax rate %48.037.1 129.3%   
Net profit margin %0.112.0 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85215,343 44.7%   
Current liabilities Rs m6,7111,960 342.3%   
Net working cap to sales %3.3157.6 2.1%  
Current ratio x1.07.8 13.0%  
Inventory Days Days16149 330.0%  
Debtors Days Days31828 1,119.5%  
Net fixed assets Rs m3,6731,209 303.7%   
Share capital Rs m317166 190.7%   
"Free" reserves Rs m3,76115,235 24.7%   
Net worth Rs m4,07815,401 26.5%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63317,595 71.8%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.5 69.1%   
Return on assets %3.45.8 59.6%  
Return on equity %0.16.6 1.8%  
Return on capital %7.710.3 74.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9641,636 58.9%   
Fx outflow Rs m6074,368 13.9%   
Net fx Rs m357-2,732 -13.1%   
CASH FLOW
From Operations Rs m1,345-1,304 -103.1%  
From Investments Rs m-2,25612,697 -17.8%  
From Financial Activity Rs m-1,200-301 399.3%  
Net Cashflow Rs m-2,11111,093 -19.0%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 1.4 1.0 135.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 29.1 323.4%  
Shareholders   20,807 28,591 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS